$134 Million is the total value of Astrantus Ltd's 208 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2021 |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-01
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CVS HEALTH CORPORATION | 2 | Q1 2022 | 1.1% |
BLOCK INC CLASS A | 2 | Q1 2022 | 1.0% |
LULULEMON ATHLETICA INC | 2 | Q1 2022 | 1.0% |
TRADE DESK, INC. CLASS A | 2 | Q1 2022 | 1.0% |
MERCK & CO., INC. | 2 | Q1 2022 | 0.8% |
NOVARTIS AG SPONSORED ADR | 2 | Q1 2022 | 0.8% |
LABORATORY CORPORATION OF AMERICA HOLDINGS | 2 | Q1 2022 | 0.8% |
WASTE CONNECTIONS, INC. | 2 | Q1 2022 | 1.0% |
ZOETIS, INC. CLASS A | 2 | Q1 2022 | 0.8% |
SIGNATURE BANK | 2 | Q1 2022 | 0.8% |
View Astrantus Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2022-05-11 |
13F-HR | 2022-02-01 |
View Astrantus Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.